Stereotactic Body Radiotherapy for Oligo-recurrence Within the Nodal Area from Colorectal Cancer

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Mar 4

PMID 24587675

Citations 12

Authors

Young Seok Seo

Mi-Sook Kim

Hyung-Jun Yoo

Won-Il Jang

Affiliations

Soon will be listed here.

Abstract

Recurrence of colorectal cancer (CRC) often presents as solitary metastases, oligometastases or oligo-recurrence. Surgical resection became the preferred treatment for patients with CRC lung and hepatic metastases. However, surgical treatment for oligo-recurrence within nodal area is not a widely accepted treatment due to due to their relative rarity and high postoperative morbidity. Stereotactic body radiotherapy (SBRT) is one of the emerging radiation treatment techniques in which a high radiation dose can be delivered to the tumor. High-dose SBRT can ablate the tumor with an efficacy similar to that achieved with surgery, especially for small tumors. However, there have been very few studies on SBRT for oligo-recurrence within nodal area, although several studies have evaluated the role of SBRT in the treatment of liver and lung metastases from CRC. This article reviews the current clinical status of and treatment methods for oligo-recurrence within nodal area from CRC, with particular emphasis on SBRT.

Citing Articles

The evolving role of radiation therapy as treatment for liver metastases.

Alrabiah K, Liao G, Shen Q, Chiang C, Dawson L J Natl Cancer Cent. 2024; 2(3):183-187.

PMID: 39036451 PMC: 11256533. DOI: 10.1016/j.jncc.2022.06.004.

Stereotactic body radiation therapy for the treatment of lymph node metastases: a retrospective mono-institutional study in a large cohort of patients.

Caivano D, Bonome P, Pezzulla D, Rotondi M, Sigillo R, De Sanctis V Front Oncol. 2023; 13:1163213.

PMID: 37601675 PMC: 10435736. DOI: 10.3389/fonc.2023.1163213.

Intensity-modulated Radiation Therapy for Lymph Node Oligo-recurrence.

Sato A, Omura M, Minagawa Y, Matsui K, Shirata R, Hongo H In Vivo. 2020; 34(5):2587-2593.

PMID: 32871788 PMC: 7652500. DOI: 10.21873/invivo.12076.

Octaarginine-modified gold nanoparticles enhance the radiosensitivity of human colorectal cancer cell line LS180 to megavoltage radiation.

Zhang X, Wang H, Coulter J, Yang R Int J Nanomedicine. 2018; 13:3541-3552.

PMID: 29950834 PMC: 6016276. DOI: 10.2147/IJN.S161157.

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression.

Roberto M, Falcone R, Mazzuca F, Archibugi L, Castaldi N, Botticelli A Medicine (Baltimore). 2018; 96(48):e9023.

PMID: 29310420 PMC: 5728821. DOI: 10.1097/MD.0000000000009023.

References

Willett C, Shellito P, Tepper J, Eliseo R, Convery K, Wood W . Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer. 1991; 67(6):1504-8. DOI: 10.1002/1097-0142(19910315)67:6<1504::aid-cncr2820670607>3.0.co;2-x. View

Jereczek-Fossa B, Piperno G, Ronchi S, Catalano G, Fodor C, Cambria R . Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer. Am J Clin Oncol. 2012; 37(3):227-33. DOI: 10.1097/COC.0b013e3182610878. View

Pilipshen S, Heilweil M, Quan S, Sternberg S, Enker W . Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984; 53(6):1354-62. DOI: 10.1002/1097-0142(19840315)53:6<1354::aid-cncr2820530623>3.0.co;2-j. View

Wanebo H, Antoniuk P, Koness R, Levy A, Vezeridis M, COHEN S . Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999; 42(11):1438-48. DOI: 10.1007/BF02235044. View

Zlobec I, Vuong T, Compton C, Lugli A, Michel R, Hayashi S . Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer. 2008; 98(2):450-6. PMC: 2361457. DOI: 10.1038/sj.bjc.6604172. View

Kavanagh B, Schefter T, Cardenes H, Stieber V, Raben D, Timmerman R . Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006; 45(7):848-55. DOI: 10.1080/02841860600904870. View

McDermott F, Hughes E, Pihl E, Johnson W, Price A . Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg. 1985; 72(1):34-7. DOI: 10.1002/bjs.1800720115. View

Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K . Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004; 101(7):1623-31. DOI: 10.1002/cncr.20539. View

Alongi F, Arcangeli S, Filippi A, Ricardi U, Scorsetti M . Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist. 2012; 17(8):1100-7. PMC: 3425528. DOI: 10.1634/theoncologist.2012-0092. View

10.

Kim M, Cho C, Yang K, Lee D, Moon S, Shin Y . Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol. 2009; 15(48):6091-5. PMC: 2797667. DOI: 10.3748/wjg.15.6091. View

11.

Wiig J, Poulsen J, Larsen S, Braendengen M, Waehre H, Giercksky K . Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg. 2002; 168(1):42-8. DOI: 10.1080/110241502317307562. View

12.

Pourhoseingholi M . Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012; 4(4):68-70. PMC: 3334381. DOI: 10.4251/wjgo.v4.i4.68. View

13.

Kelly H, Goldberg R . Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol. 2005; 23(20):4553-60. DOI: 10.1200/JCO.2005.17.749. View

14.

Palmer G, Martling A, Cedermark B, Holm T . A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2006; 14(2):447-54. DOI: 10.1245/s10434-006-9256-9. View

15.

Bentzen S, Atasoy B, Daley F, Dische S, Richman P, Saunders M . Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol. 2005; 23(24):5560-7. DOI: 10.1200/JCO.2005.06.411. View

16.

Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622):1155-9. DOI: 10.1126/science.1082504. View

17.

Delpero J, Pol B, Le Treut P, Bardou V, Moutardier V, Hardwigsen J . Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg. 1998; 85(3):372-6. DOI: 10.1046/j.1365-2168.1998.00583.x. View

18.

Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas M, Feig B, Hunt K . Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006; 49(2):175-82. DOI: 10.1007/s10350-005-0276-5. View

19.

Pawlik T, Scoggins C, Zorzi D, Abdalla E, Andres A, Eng C . Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241(5):715-22, discussion 722-4. PMC: 1357126. DOI: 10.1097/01.sla.0000160703.75808.7d. View

20.

Timmerman R . An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 2008; 18(4):215-22. DOI: 10.1016/j.semradonc.2008.04.001. View